Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Nurse Faculty Loan Program-Program Specific Data Form and Annual Performance Report Financial Data Form, OMB No. 0915-0314-Revision, 7315-7316 [2020-02408]

Download as PDF Federal Register / Vol. 85, No. 26 / Friday, February 7, 2020 / Notices approved under OMB control number 0910–0572. III. Electronic Access Persons with access to the internet may obtain the draft guidance at either https://www.fda.gov/Drugs/Guidance ComplianceRegulatoryInformation/ Guidances/default.htm, http:// www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatory Information/Guidances/default.htm, or https://www.regulations.gov. Dated: February 3, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–02421 Filed 2–6–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Nurse Faculty Loan Program—Program Specific Data Form and Annual Performance Report Financial Data Form, OMB No. 0915– 0314—Revision Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. DATES: Comments on this ICR should be received no later than April 7, 2020. ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA Information Collection Clearance Officer, 14N136B, 5600 Fishers Lane, Rockville, MD 20857. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov or call Lisa Wright-Solomon, the HRSA Information Collection Clearance Officer at (301) 443–1984. SUPPLEMENTARY INFORMATION: When submitting comments or requesting jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:42 Feb 06, 2020 Jkt 250001 information, please include the ICR title for reference. Information Collection Request Title: Nurse Faculty Loan Program—Program Specific Data Form and Annual Performance Report Financial Data Form OMB No. 0915–0314—Revision. Abstract: This clearance request is for approval of both the Nurse Faculty Loan Program (NFLP) Program Specific Data Form and the Annual Performance Report (APR) Financial Data Form. The APR Financial Data Form is currently approved under OMB Approval No. 0915–0314 and the Program Specific Data Form is currently approved under OMB Approval No. 0915–0378, both with the expiration date of July 31, 2020. For program efficiency, HRSA is combining these previously separate ICRs under OMB No. 0915–0314 and will be discontinuing OMB No. 0915– 0378. Need and Proposed Use of the Information: Section 846A of the Public Health Service Act provides the Secretary of HHS with the authority to enter into an agreement with schools of nursing for the establishment and operation of a student loan fund to increase the number of qualified nurse faculty. Under the agreement, HRSA makes awards to the school for the NFLP loan fund, which schools must maintain in a distinct account. The school of nursing makes loans from the NFLP account to students enrolled full-time or, at the discretion of the Secretary, part-time, in a master’s or doctoral nursing education program that will prepare them to become qualified nursing faculty. Following graduation from the NFLPlending school, loan recipients may receive up to 85 percent NFLP loan cancellation over a 4-year period in exchange for service as full-time faculty at a school of nursing. The NFLPlending school collects any portion of the loan that it has not cancelled and any loans that go into repayment due to default and deposits these monies into the NFLP loan fund to make additional NFLP loans. The NFLP Program Specific Data Form is a required electronic attachment within the NFLP application materials. The data provided in the form is essential for the formula-based criteria used to determine the award amount to the applicant schools. The form collects application-related data from applicants such as the amount requested, number of students the school will fund, tuition information, and projected unused loan fund balance. Approval of the NFLP Program Specific Data Form allows HRSA to continue to capture data to generate the formula-based awards for PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 7315 the NFLP program. This data collection assists HRSA in streamlining the application submission process, enabling an efficient award determination process, and facilitating reporting on the use of funds and analysis of program outcomes. The NFLP–APR Financial Data Form is an online form that exists in the HRSA Electronic Handbooks Performance Report module. The NFLP– APR Financial Data Form collects outcome and financial data to capture the NFLP loan fund account activity related to financial receivables, disbursements, and borrower account data related to employment status, loan cancellation, loan repayment, and collections. Participating schools provide HHS with current and cumulative information on: (1) NFLP loan funds received, (2) number and amount of NFLP loans made, (3) number and amount of loans cancelled, (4) number and amount of loans in repayment, (5) loan default rate percent, (6) number of NFLP graduates employed as nurse faculty, and (7) other related loan fund costs and activities. The school of nursing must keep records of all NFLP loan fund transactions. HRSA uses the NFLP–APR Financial Data Form to monitor grantee performance by collecting information related to the NFLP loan fund operations and financial activities for a specified reporting period (July 1 through June 30 of the academic year). Participating schools are required to complete and submit the NFLP–APR Financial Data Form annually. The data provided in the form is essential for HRSA to monitor the school’s use of NFLP funds in accordance with the statute and program guidelines. Approval of the NFLP–APR Financial Data Form extension will allow HRSA to continue to monitor program performance and program outcome. Likely Respondents: Participating NFLP schools and applicants to the NFLP program. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to E:\FR\FM\07FEN1.SGM 07FEN1 7316 Federal Register / Vol. 85, No. 26 / Friday, February 7, 2020 / Notices transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Total responses Average burden per response (in hours) Total burden hours Nurse Faculty Loan Program—Program Specific Data Form ................................................................................. Nurse Faculty Loan Program—Annual Performance Report Financial Data Form ................................................. 90 1 90 8 720 260 1 260 6 1,560 Total Burden ................................................................. 350 ........................ 350 ........................ 2,280 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. section 564 of the FD&C Act, subject to the terms of any authorization issued under that section. DATES: The determination and declaration took effect February 4, 2020. FOR FURTHER INFORMATION CONTACT: Robert P. Kadlec, M.D., MTM&H, MS, Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, 200 Independence Avenue SW, Washington, DC 20201, Telephone (202) 205–2882 (this is not a toll free number). [FR Doc. 2020–02408 Filed 2–6–20; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4165–15–P I. Background DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Determination of Public Health Emergency Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to section 564 of the Federal Food, Drug, and Cosmetic (FD&C) Act. On February 4, 2020, the Secretary determined pursuant to his authority under section 564 of the FD&C Act that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves a novel (new) coronavirus (nCoV) first detected in Wuhan City, Hubei Province, China in 2019 (2019-nCoV). On the basis of this determination, he also declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of this novel coronavirus (2019-nCoV) pursuant to SUMMARY: jbell on DSKJLSW7X2PROD with NOTICES Number of responses per respondent VerDate Sep<11>2014 17:42 Feb 06, 2020 Jkt 250001 Under Section 564 of the FD&C Act, 21 U.S.C. 360bbb–3, the Commissioner of the Food and Drug Administration (FDA), acting under delegated authority from the Secretary of HHS, may issue an Emergency Use Authorization (EUA) authorizing (1) the emergency use of an unapproved drug, an unapproved or uncleared device, or an unlicensed biological product; or (2) an unapproved use of an approved drug, approved or cleared device, or licensed biological product. Before an EUA may be issued, the Secretary of HHS must declare that circumstances exist justifying the authorization based on one of four determinations: (1) A determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a, chemical, biological, radiological, or nuclear (‘‘CBRN’’) agent or agents; (2) the identification of a material threat by the Secretary of Homeland Security pursuant to section 319F–2 of the Public Health Service (PHS) Act 1 sufficient to affect national security or the health and security of United States citizens living abroad; (3) a determination by the Secretary of Defense that there is a military 1 42 PO 00000 U.S.C. 247d–6b. Frm 00052 Fmt 4703 Sfmt 4703 emergency, or a significant potential for a military emergency, involving a heightened risk to United States military forces, including personnel operating under the authority of title 10 or title 50, of attack with (i) a biological, chemical, radiological, or nuclear agent or agents; or (ii) an agent or agents that may cause, or are otherwise associated with, an imminently life-threatening and specific risk to United States military forces; or (4) a determination by the Secretary that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of United States citizens living abroad, and that involves a CBRN agent or agents, or a disease or condition that may be attributable to such agent or agents.2 Based on any of these four determinations, the Secretary of HHS may then declare that circumstances exist that justify the EUA, at which point the FDA Commissioner may issue an EUA if the criteria for issuance of an authorization under section 564 of the FD&C Act are met. The determination of a public health emergency, and the declaration that circumstances exist justifying emergency use of in vitro diagnostics for detection and/or diagnosis of the novel coronavirus (2019-nCoV) by the Secretary of HHS, as described below, enable the FDA Commissioner to issue EUAs for certain in vitro diagnostics for emergency use under section 564 of the FD&C Act. The Centers for Disease Control and Prevention (CDC) requested that the FDA issue an EUA for its in 2 As amended by the Pandemic and All-Hazards Preparedness Reauthorization Act, Public Law 113– 5, the Secretary may make determination of a public health emergency, or a significant potential for a public health emergency, under section 564 of the FD&C Act. The Secretary is no longer required to make a determination of a public health emergency in accordance with section 319 of the PHS Act, 42 U.S.C. 247d to support a determination or declaration made under section 564 of the FD&C Act. E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 85, Number 26 (Friday, February 7, 2020)]
[Notices]
[Pages 7315-7316]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02408]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Proposed Collection: 
Public Comment Request; Information Collection Request Title: Nurse 
Faculty Loan Program--Program Specific Data Form and Annual Performance 
Report Financial Data Form, OMB No. 0915-0314--Revision

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement for opportunity for public 
comment on proposed data collection projects of the Paperwork Reduction 
Act of 1995, HRSA announces plans to submit an Information Collection 
Request (ICR), described below, to the Office of Management and Budget 
(OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the 
public regarding the burden estimate, below, or any other aspect of the 
ICR.

DATES: Comments on this ICR should be received no later than April 7, 
2020.

ADDRESSES: Submit your comments to [email protected] or mail the HRSA 
Information Collection Clearance Officer, 14N136B, 5600 Fishers Lane, 
Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
draft instruments, email [email protected] or call Lisa Wright-
Solomon, the HRSA Information Collection Clearance Officer at (301) 
443-1984.

SUPPLEMENTARY INFORMATION: When submitting comments or requesting 
information, please include the ICR title for reference.
    Information Collection Request Title: Nurse Faculty Loan Program--
Program Specific Data Form and Annual Performance Report Financial Data 
Form OMB No. 0915-0314--Revision.
    Abstract: This clearance request is for approval of both the Nurse 
Faculty Loan Program (NFLP) Program Specific Data Form and the Annual 
Performance Report (APR) Financial Data Form. The APR Financial Data 
Form is currently approved under OMB Approval No. 0915-0314 and the 
Program Specific Data Form is currently approved under OMB Approval No. 
0915-0378, both with the expiration date of July 31, 2020. For program 
efficiency, HRSA is combining these previously separate ICRs under OMB 
No. 0915-0314 and will be discontinuing OMB No. 0915-0378.
    Need and Proposed Use of the Information: Section 846A of the 
Public Health Service Act provides the Secretary of HHS with the 
authority to enter into an agreement with schools of nursing for the 
establishment and operation of a student loan fund to increase the 
number of qualified nurse faculty.
    Under the agreement, HRSA makes awards to the school for the NFLP 
loan fund, which schools must maintain in a distinct account. The 
school of nursing makes loans from the NFLP account to students 
enrolled full-time or, at the discretion of the Secretary, part-time, 
in a master's or doctoral nursing education program that will prepare 
them to become qualified nursing faculty. Following graduation from the 
NFLP-lending school, loan recipients may receive up to 85 percent NFLP 
loan cancellation over a 4-year period in exchange for service as full-
time faculty at a school of nursing. The NFLP-lending school collects 
any portion of the loan that it has not cancelled and any loans that go 
into repayment due to default and deposits these monies into the NFLP 
loan fund to make additional NFLP loans.
    The NFLP Program Specific Data Form is a required electronic 
attachment within the NFLP application materials. The data provided in 
the form is essential for the formula-based criteria used to determine 
the award amount to the applicant schools. The form collects 
application-related data from applicants such as the amount requested, 
number of students the school will fund, tuition information, and 
projected unused loan fund balance. Approval of the NFLP Program 
Specific Data Form allows HRSA to continue to capture data to generate 
the formula-based awards for the NFLP program. This data collection 
assists HRSA in streamlining the application submission process, 
enabling an efficient award determination process, and facilitating 
reporting on the use of funds and analysis of program outcomes.
    The NFLP-APR Financial Data Form is an online form that exists in 
the HRSA Electronic Handbooks Performance Report module. The NFLP-APR 
Financial Data Form collects outcome and financial data to capture the 
NFLP loan fund account activity related to financial receivables, 
disbursements, and borrower account data related to employment status, 
loan cancellation, loan repayment, and collections. Participating 
schools provide HHS with current and cumulative information on: (1) 
NFLP loan funds received, (2) number and amount of NFLP loans made, (3) 
number and amount of loans cancelled, (4) number and amount of loans in 
repayment, (5) loan default rate percent, (6) number of NFLP graduates 
employed as nurse faculty, and (7) other related loan fund costs and 
activities.
    The school of nursing must keep records of all NFLP loan fund 
transactions. HRSA uses the NFLP-APR Financial Data Form to monitor 
grantee performance by collecting information related to the NFLP loan 
fund operations and financial activities for a specified reporting 
period (July 1 through June 30 of the academic year). Participating 
schools are required to complete and submit the NFLP-APR Financial Data 
Form annually.
    The data provided in the form is essential for HRSA to monitor the 
school's use of NFLP funds in accordance with the statute and program 
guidelines. Approval of the NFLP-APR Financial Data Form extension will 
allow HRSA to continue to monitor program performance and program 
outcome.
    Likely Respondents: Participating NFLP schools and applicants to 
the NFLP program.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions; to develop, acquire, install, and utilize technology and 
systems for the purpose of collecting, validating, and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information; to search data sources; to complete and 
review the collection of information; and to

[[Page 7316]]

transmit or otherwise disclose the information. The total annual burden 
hours estimated for this ICR are summarized in the table below.

                                     Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
            Form name                Number of     responses per       Total       per  response   Total burden
                                    respondents     respondent       responses      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Nurse Faculty Loan Program--                  90               1              90               8             720
 Program Specific Data Form.....
Nurse Faculty Loan Program--                 260               1             260               6           1,560
 Annual Performance Report
 Financial Data Form............
                                 -------------------------------------------------------------------------------
    Total Burden................             350  ..............             350  ..............           2,280
----------------------------------------------------------------------------------------------------------------

    HRSA specifically requests comments on (1) the necessity and 
utility of the proposed information collection for the proper 
performance of the agency's functions; (2) the accuracy of the 
estimated burden; (3) ways to enhance the quality, utility, and clarity 
of the information to be collected; and (4) the use of automated 
collection techniques or other forms of information technology to 
minimize the information collection burden.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-02408 Filed 2-6-20; 8:45 am]
 BILLING CODE 4165-15-P